filmov
tv
Upadacitinib in SLE
Показать описание
Dr. Peter Nash reports on abstract OP0139 EULAR 2023 in Milan, Italy.
RheumNow
Rheumatoid
arthritis
Rheumatology
Lupus
Vasculitis
Рекомендации по теме
0:04:35
Upadacitinib in SLE
0:04:00
SLE Trial: Dual BTK JAK Blockade compared Upadacitinib Monotherapy
0:03:22
Do Patients on Upadacitinib Need Labs? Dr. Janet Pope
0:42:40
The SLEek Study
0:03:02
SELECT-GCA: Upadacitinib in Giant Cell Arteritis
0:03:18
Upadacitinib for Pain: Is That Real?
0:26:28
Congress Author Podcast - ACR 2019 Upadacitinib
0:32:30
SLE Panel Review - EULAR 2023
0:04:25
Upadacitinib (Rinvoq) - IBD treatments explained by the experts
0:03:22
JAK/TYK Inhibitors in SLE
0:01:06
Study shows higher doses of upadacitinib produce added benefit in moderate to severe AD
0:01:03
Upadacitinib effective for treating hand eczema in AD patients
0:17:50
Rheumatology Author Professor Mease: Upadacitinib
0:18:39
July 2024 Monthly Publications Podcast
0:24:08
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
0:06:11
Efficacy and Safety of Baricitinib in Lupus Nephritis
0:00:16
Upadacitinib
0:36:51
The Expanding Role of JAK Inhibitors Across IMIDs
0:16:47
RheumNow Podcast – Tricked Up Lupus Criteria (8.9.19)
0:05:14
Effect of Ancestry on Therapeutic Outcomes in SLE
0:01:59
Prospective Study of Complement Levels in Lupus Pregnancy: Dr. Kathryn Dao
0:00:51
Rinvoq update: Holy Side Effects Batman!!! #ankylosingspondylitis #autoimmunedisease #scleroderma
0:05:49
TLL-018 (a JAK1/TYK2 agent) vs. Tofacitinib in RA
0:00:36
Anifrolumab - In a nutshell
0:04:35
0:04:00
0:03:22
0:42:40
0:03:02
0:03:18
0:26:28
0:32:30
0:04:25
0:03:22
0:01:06
0:01:03
0:17:50
0:18:39
0:24:08
0:06:11
0:00:16
0:36:51
0:16:47
0:05:14
0:01:59
0:00:51
0:05:49
0:00:36